Vector Laboratories' blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
NEWARK, Calif.July 26, 2022 Diverse and deep financial and commercial experience will help lead Vector Laboratories’ ongoing expansion strategy Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced that Vatea Herman, CPA... Read more
NEWARK, Calif.July 19, 2022 Offers a new, promising frontier to advance research and exploration of diseased and healthy tissue. Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the launch of its... Read more
NEWARK, Calif.March 29, 2022 Woo bringing key manufacturing experience and turnaround time reductions to proteomic and glycomic-focused company Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced that Kum Ming Woo has... Read more
BURLINGAME, Calif.March 16, 2022 Relocation driven by increased demand for Vector Laboratories’ growing areas of focus, glycomics and proteomics Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in... Read more
BURLINGAME, Calif.February 2, 2022 Key appointment will support the company’s commercial growth plans to deliver proteomics and protein innovations worldwide Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of... Read more
BURLINGAME, Calif.December 14, 2021 Mr. Morales’ decades of financial experience in the life sciences sector will drive Vector Laboratories’ ongoing expansion strategy Vector Laboratories, the pioneer and leader in the development and manufacture of protein... Read more
BURLINGAME, Calif.November 16, 2021 Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has promoted Pamela James, Ph.D., to the position of... Read more
BURLINGAME, Calif.September 7, 2021 Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has closed a $124 million cash buyout, backed by... Read more
Susteren, Netherlands (13th April 2021) – Nordic-MUbio announces the acquisition of Scicons who provide highly cited monoclonal antibodies used by researchers worldwide as a reliable tool for dsRNA detection. The team at Nordic-MUBio is committed... Read more
BURLINGAME, Calif.November 14, 2018 Vector Laboratories, a Maravai LifeSciences company and leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today that it has achieved ISO 9001:2015 certification. This... Read more
